Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024
Sensus Healthcare (Nasdaq: SRTS), a medical device company specializing in non-invasive treatments for oncological and non-oncological conditions, has announced its upcoming second quarter 2024 financial results and business update conference call. The call is scheduled for Thursday, August 8, 2024, at 4:30 p.m. Eastern time.
Key points:
- Management will discuss Q2 2024 financial results
- A business update and discussion on recent and upcoming milestones will be provided
- Participants can pre-register for the call or dial in directly
- A webcast will be available on the company's Investor Relations website
- A telephone replay will be accessible until September 8th
Sensus Healthcare (Nasdaq: SRTS), un'azienda di dispositivi medici specializzata in trattamenti non invasivi per condizioni oncologiche e non oncologiche, ha annunciato la prossima conferenza telefonica sui risultati finanziari e l'aggiornamento aziendale per il secondo trimestre del 2024. La chiamata è programmata per giovedì 8 agosto 2024, alle 16:30 ora orientale.
Punti chiave:
- La direzione discuterà i risultati finanziari del secondo trimestre 2024
- Sarà fornito un aggiornamento aziendale e si discuterà di traguardi recenti e futuri
- I partecipanti possono pre-registrarsi per la chiamata o chiamare direttamente
- Una trasmissione web sarà disponibile sul sito web delle Relazioni con gli Investitori dell'azienda
- Una registrazione telefonica sarà accessibile fino all'8 settembre
Sensus Healthcare (Nasdaq: SRTS), una empresa de dispositivos médicos especializada en tratamientos no invasivos para condiciones oncológicas y no oncológicas, ha anunciado su próxima conferencia telefónica sobre los resultados financieros y la actualización del negocio para el segundo trimestre de 2024. La llamada está programada para jueves, 8 de agosto de 2024, a las 4:30 p.m. hora del Este.
Puntos clave:
- La gerencia discutirá los resultados financieros del segundo trimestre de 2024
- Se proporcionará una actualización del negocio y se hablará sobre hitos recientes y futuros
- Los participantes pueden pre-registrarse para la llamada o conectarse directamente
- Se dispondrá de una transmisión web en el sitio web de Relaciones con Inversionistas de la compañía
- Una repetición telefónica estará disponible hasta el 8 de septiembre
Sensus Healthcare (Nasdaq: SRTS)는 종양 및 비종양 질환에 대한 비침습적 치료를 전문으로 하는 의료기기 회사로, 다가오는 2024년 2분기 재무 결과 및 사업 업데이트 컨퍼런스 콜을 발표했습니다. 이 통화는 2024년 8월 8일 목요일, 동부 표준시 오후 4시 30분으로 예정되어 있습니다.
주요 사항:
- 경영진은 2024년 2분기 재무 결과를 논의할 것입니다
- 최근 및 향후 이정표에 대한 사업 업데이트와 논의가 제공될 것입니다
- 참가자는 통화에 사전 등록하거나 직접 전화할 수 있습니다
- 회사의 투자자 관계 웹사이트에서 웹캐스트가 제공됩니다
- 전화 녹음은 9월 8일까지 이용 가능합니다
Sensus Healthcare (Nasdaq: SRTS), une entreprise de dispositifs médicaux spécialisée dans les traitements non invasifs pour des conditions oncologiques et non oncologiques, a annoncé sa prochaine conférence téléphonique sur les résultats financiers et la mise à jour des affaires pour le deuxième trimestre 2024. L'appel est prévu pour jeudi 8 août 2024, à 16h30, heure de l'Est.
Points clés :
- La direction discutera des résultats financiers du deuxième trimestre 2024
- Une mise à jour des affaires et une discussion sur les jalons récents et à venir seront fournies
- Les participants peuvent se pré-enregistrer pour l'appel ou se connecter directement
- Un webinaire sera disponible sur le site des Relations Investisseurs de l'entreprise
- Une rediffusion téléphonique sera accessible jusqu'au 8 septembre
Sensus Healthcare (Nasdaq: SRTS), ein Unternehmen für medizinische Geräte, das sich auf nicht-invasive Behandlungen für onkologische und nicht-onkologische Erkrankungen spezialisiert hat, hat seine bevorstehende Telefonkonferenz zu den finanziellen Ergebnissen und Unternehmensaktualisierungen für das zweite Quartal 2024 angekündigt. Der Anruf ist für Donnerstag, den 8. August 2024, um 16:30 Uhr Eastern Time angesetzt.
Wichtige Punkte:
- Das Management wird die finanziellen Ergebnisse des 2. Quartals 2024 erörtern
- Ein Unternehmensupdate und Diskussionen über kürzliche und bevorstehende Meilensteine werden bereitgestellt
- Teilnehmer können sich im Voraus für den Anruf registrieren oder direkt anrufen
- Eine Webcast wird auf der Investor Relations-Website des Unternehmens verfügbar sein
- Eine telefonische Wiederholung ist bis zum 8. September zugänglich
- Sensus Healthcare is maintaining transparency by hosting a quarterly financial results call
- The company will provide updates on recent and upcoming milestones, indicating potential growth opportunities
- None.
BOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may access the conference call by dialing, 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until September 8th, and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International). At the system prompt, dial the replay code – 2699495 – followed by the # sign. Playback will automatically begin. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com
# # #
FAQ
When is Sensus Healthcare (SRTS) releasing its Q2 2024 financial results?
How can investors participate in Sensus Healthcare's (SRTS) Q2 2024 earnings call?
Will there be a replay available for Sensus Healthcare's (SRTS) Q2 2024 earnings call?